Pretreatment Metabolic Tumor Volume As A Prognostic Factor In HPV‐associated Oropharyngeal Cancer In The Context Of AJCC 8th Edition Staging by J. Floberg, T. DeWees, R. Chin, A. Garsa, F. Dehdashti, B. Nussenbaum, P. Oppelt, D. Adkins, H. Gay, W. Thorstad

10.1088/1361-6560/aa73cc

Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.

M. Folkert (2017)

10.2307/1912557

Likelihood Ratio Tests for Model Selection and Non-Nested Hypotheses

Q. Vuong (1989)

10.1186/s40463-014-0033-7

Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery

H. Zhang (2014)

10.1002/ijc.22980

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen

S. J. Smeets (2007)

10.1056/NEJMoa0912217

Human papillomavirus and survival of patients with oropharyngeal cancer.

K. Ang (2010)

10.1016/j.ijrobp.2011.10.023

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

C. Tang (2012)

10.1200/JCO.2015.64.6448

Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.

K. Dahlstrom (2016)

10.1002/cncr.30931

Comparison of unilateral versus bilateral intensity‐modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil

R. Chin (2017)

10.1002/hed.24465

Prognostic value of FDG‐PET volumetric parameters in patients with p16‐positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy

K. Kim (2016)

10.1016/j.ijrobp.2015.08.033

Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.

B. Chera (2015)

Prognostic value of (18) F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma

AA Garsa (2013)

10.1200/JCO.2014.58.6412

Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.

S. Huang (2015)

Likelihood ratio test for model selection and nonnested hypotheses. Econometrica

QH Vuong (1989)

10.2967/jnumed.111.101402

18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma

Remy Lim (2012)

10.1016/S1470-2045(15)00560-4

Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

B. O'Sullivan (2016)

10.1016/S0167-9473(98)00096-6

An application of changepoint methods in studying the effect of age on survival in breast cancer

C. Contal (1999)

10.1002/hed.24287

Tumor volume as a predictor of survival in human papillomavirus–positive oropharyngeal cancer

Kara S. Davis (2016)

10.1007/978-3-319-40618-3_10

HPV-Mediated (p16+) Oropharyngeal Cancer

B. O'Sullivan (2017)

10.1016/j.radonc.2011.05.040

Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.

J. Murphy (2011)

10.1097/PAS.0b013e3181e84652

p16 Positive Oropharyngeal Squamous Cell Carcinoma:An Entity With a Favorable Prognosis Regardless of Tumor HPV Status

J. Lewis (2010)

10.1007/s13139-010-0063-7

Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery

Kyu-Ho Choi (2011)

10.1016/j.ijrobp.2014.12.023

Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.

D. Schwartz (2015)

10.1002/hed.24486

Reevaluation of postoperative radiation dose in the management of human papillomavirus–positive oropharyngeal cancer

R. Chin (2016)

10.1001/jamaoto.2013.4973

Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma.

I. Nixon (2013)

10.1016/j.radonc.2012.02.009

Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.

B. O'Sullivan (2012)

10.2967/jnumed.111.099531

18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging

Elizabeth H Dibble (2012)

10.2967/jnumed.114.141424

Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy

R. Jeraj (2015)

10.1016/S0360-3016(03)00346-8

Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.

I. Ciernik (2003)

10.3857/roj.2011.29.4.243

FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer

Giwon Kim (2011)

10.1200/JCO.2012.44.0164

Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

B. O'Sullivan (2013)

10.2967/jnumed.113.133801

Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis

K. Pak (2014)

10.1007/s00259-014-2961-x

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

R. Boellaard (2014)

10.1200/JCO.2016.66.6081

Human Papillomavirus and Oropharyngeal Cancer Stage.

M. Gillison (2016)

10.1007/s13566-012-0065-4

Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma

Adam A. Garsa (2012)

10.2967/jnumed.112.119289

Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma

Nai-Ming Cheng (2013)

Phase 2 Trial of Deintensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma

BS Chera (2015)

10.1016/j.ijrobp.2008.10.060

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

T. La (2009)

10.1200/JCO.2014.55.3925

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

P. Nguyen-Tan (2014)

10.1016/j.cden.2017.08.008

Human Papillomavirus and Oropharyngeal Cancer.

T. Tanaka (2018)